Y-mAbs Therapeutics, Inc. Prices 6M Share IPO at $16/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Hungarian Gripen jet crashes, no injuries reported, PM Magyar says
Y-mAbs Therapeutics (YMAB) IPO Opens 67% Higher
September 21, 2018 11:03 AM EDTToday's IPO for Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) opened for tradign at $26.50 after pricing 6,000,000 shares of common stock at a public offering price of $16.00 per share.
In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional... More
